1. Home
  2. MLAB vs EHAB Comparison

MLAB vs EHAB Comparison

Compare MLAB & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • EHAB
  • Stock Information
  • Founded
  • MLAB 1982
  • EHAB 2014
  • Country
  • MLAB United States
  • EHAB United States
  • Employees
  • MLAB N/A
  • EHAB N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • EHAB Hospital/Nursing Management
  • Sector
  • MLAB Industrials
  • EHAB Health Care
  • Exchange
  • MLAB Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • MLAB 341.1M
  • EHAB 330.2M
  • IPO Year
  • MLAB N/A
  • EHAB N/A
  • Fundamental
  • Price
  • MLAB $72.96
  • EHAB $8.19
  • Analyst Decision
  • MLAB Buy
  • EHAB Buy
  • Analyst Count
  • MLAB 2
  • EHAB 3
  • Target Price
  • MLAB $113.50
  • EHAB $8.67
  • AVG Volume (30 Days)
  • MLAB 119.0K
  • EHAB 591.5K
  • Earning Date
  • MLAB 08-05-2025
  • EHAB 08-06-2025
  • Dividend Yield
  • MLAB 0.96%
  • EHAB N/A
  • EPS Growth
  • MLAB N/A
  • EHAB N/A
  • EPS
  • MLAB N/A
  • EHAB N/A
  • Revenue
  • MLAB $242,351,000.00
  • EHAB $1,037,800,000.00
  • Revenue This Year
  • MLAB $5.38
  • EHAB $4.66
  • Revenue Next Year
  • MLAB $5.25
  • EHAB $4.99
  • P/E Ratio
  • MLAB N/A
  • EHAB N/A
  • Revenue Growth
  • MLAB 8.33
  • EHAB N/A
  • 52 Week Low
  • MLAB $55.45
  • EHAB $6.47
  • 52 Week High
  • MLAB $155.12
  • EHAB $10.91
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 50.59
  • EHAB 62.73
  • Support Level
  • MLAB $66.66
  • EHAB $7.94
  • Resistance Level
  • MLAB $70.70
  • EHAB $8.16
  • Average True Range (ATR)
  • MLAB 5.49
  • EHAB 0.33
  • MACD
  • MLAB 1.47
  • EHAB 0.16
  • Stochastic Oscillator
  • MLAB 85.58
  • EHAB 94.21

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: